encephalitis

Documents about encephalitis

• Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.#914707ClinicalTrials.gov
• Clinicolaboratory Predictors of Outcome in Children With Encephalitis#878773ClinicalTrials.gov
• Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)#891477ClinicalTrials.gov
• CPI Combination Therapy for Autoimmune Encephalitis#893063ClinicalTrials.gov
• CASPR2 Encephalitis Initial Symptoms#885051ClinicalTrials.gov
• VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults#668858ClinicalTrials.gov
• A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis#907121ClinicalTrials.gov
• Tick-borne Encephalitis and Positive Borrelial Antibodies#311155ClinicalTrials.gov
• IL-2 in Refractory Autoimmune Encephalitis#993958ClinicalTrials.gov
• Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection#832169ClinicalTrials.gov
• Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus#884522ClinicalTrials.gov
• Tick-borne Encephalitis and Borrelial Antibodies in Serum#121408ClinicalTrials.gov
• QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001#802333ClinicalTrials.gov
• Predicting and Monitoring Outcomes in Autoimmune Encephalitis#813118ClinicalTrials.gov
• Immunogenicity Study of the Japanese Encephalitis Vaccine IC51#878981ClinicalTrials.gov
• Diffusion Imaging in Acute Auto-immune Encephalitis#825553ClinicalTrials.gov
• Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab#830228ClinicalTrials.gov
• Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel#855558ClinicalTrials.gov
• Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population#992411ClinicalTrials.gov
• A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease#889908ClinicalTrials.gov
• New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes#121345ClinicalTrials.gov
• Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis#200215ClinicalTrials.gov
• Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis#843480ClinicalTrials.gov
• Clinical-immunological Features of Anti-NMDAR Encephalitis#915348ClinicalTrials.gov
• Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis#252977ClinicalTrials.gov
• Encephalitis Lethargica: The Sleeping Sickness from a dualistic perspective#629654ScholarWorks@GSU
• Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis#806183ClinicalTrials.gov
• Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine#862196ClinicalTrials.gov
• A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2#871420ClinicalTrials.gov
• Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease#842503ClinicalTrials.gov
• Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects#912245ClinicalTrials.gov
• Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj#154724ClinicalTrials.gov
• Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age#874073ClinicalTrials.gov
• Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines#429636ClinicalTrials.gov
• Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination#812429ClinicalTrials.gov
• Long-term Follow up of Patient With Anti-GABAbr Antibodies Associated-encephalitis.#835091ClinicalTrials.gov
• Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment#845558ClinicalTrials.gov
• Post-licensure Safety Study of IMOJEV® in Thailand#969157ClinicalTrials.gov
• Real-world effectiveness of EV-A71 vaccine against encephalitis in children#5168Europe PMC
• Acute encephalitis syndrome and Japanese encephalitis in India: insights from a nationally representative laboratory surveillance network, 2014-2023.#221151NCBI PubMed Central
• FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years#993584ClinicalTrials.gov
• Tick-borne encephalitis vaccination coverage among outdoor workers in Sweden: a nationwide survey.#160148PubMed
• Long-term outcomes of childhood encephalitis in Australia: burden and predictors from the Australian childhood encephalitis (ACE) prospective multicentre cohort.#458731NCBI PubMed Central
• Humoral Response to Tick-borne Encephalitis Vaccine in Elderly#842991ClinicalTrials.gov
• Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term#859523ClinicalTrials.gov
• Clinical Features and Outcomes of VZV CNS Infections#861479ClinicalTrials.gov
• Cross-Reactivity of 15 JEV Antigen-Directed Rabbit Antisera With Three Clinically Important JEV Serogroup Members: WNV, MVEV, and SLEV#921669DigitalCommons@USU
• Optimized use of the FilmArray Meningitis/Encephalitis panel for early discontinuation of antibiotic therapy#178192HAL (France)
• IVIG - West Nile Encephalitis: Safety and Efficacy#833632ClinicalTrials.gov
• One Health Investigation into Fatal Encephalitis caused by Pigeon Paramyxovirus Type 1, France#205854HAL (France)